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rosis [10], which can be detected noninva-
sively by MDCT.
Coronary artery disease is commonly cit-
ed as a mechanism underlying diastolic dys-
function [11]. Many of the same factors that 
contribute to atherosclerosis may also pro-
duce LV diastolic dysfunction by either direct 
mechanisms (e.g., hypertension and age-relat-
ed vascular stiffening) or secondarily via cor-
onary artery disease progression and resulting 
changes in myocardial compliance [11].
There are limited and controversial pub-
lished data on the relationship of CAC to LV 
diastolic function. Edvardsen et al. [12] re-
ported that coronary atherosclerosis is asso-
ciated with depressed regional LV systolic 
and diastolic wall strain measured by MRI 
tagging. Colletti et al. [13] found that a CAC 
score greater than 100 predicts an increased 
likelihood of clinically unsuspected LV re-
gional wall motion abnormalities, which are 
C
ardiovascular disease is the most 
frequent cause of death and dis-
ability in patients with type 2 di-
abetes mellitus (DM2).
DM2 is responsible for diverse cardiovas-
cular complications such as increased coro-
nary atherosclerosis and left ventricular (LV) 
dysfunction. LV diastolic dysfunction is high-
ly prevalent in DM2 [1, 2], representing the 
earliest preclinical manifestation of LV dys-
function in patients with this condition [3–6].
Over the past decade, cardiac MRI has been 
widely accepted as the reference standard for 
the assessment of cardiac structure and func-
tion because of its high spatial and temporal 
resolution, excellent image quality, and lack 
of geometric assumptions [7]. Cardiac MRI 
offers a variety of alternative approaches for 
evaluating diastolic function [8, 9].
The presence of coronary artery calcium 
(CAC) is indicative of coronary atheroscle-
OBJECTIVE. The purpose of this study was to compare cardiac MRI–derived param-
eters of left ventricular (LV) diastolic function between uncomplicated type 2 diabetes mel-
litus (DM2) and normoglycemic control subjects and to evaluate whether these parameters of 
LV diastolic function are related to coronary atherosclerosis.
SUBJECTS AND METHODS. We prospectively studied 41 subjects with DM2 and 
21 normoglycemic control subjects (30 women and 32 men; mean age, 57.2 ± 7.1 [SD] years) 
with no evidence of overt cardiovascular disease. We used cardiac MRI to measure LV vol-
umes, LV peak filling rate (PFR), and transmitral flow and CT to determine coronary artery 
calcium scores.
RESULTS. Absolute values of the peak filling rate (PFR) were significantly lower in 
DM2 patients than in control subjects (mean ± SD, 293.2 ± 51.7 vs 375.7 ± 102.8 mL/s, re-
spectively; p < 0.001). Mitral peak E velocities (mean ± SD, 42.8 ± 10.7 vs 48.8 ± 10.4 cm/s; 
p = 0.040) and peak E velocity–to–peak A velocity ratios (0.88 ± 0.3 vs 1.1 ± 0.3; p = 0.002) 
were also lower in DM2 patients compared with control subjects. DM2 patients with coro-
nary artery calcification showed a lower PFR normalized to stroke volume (SV) (mean ± SD, 
4.4 ± 1.0 vs 5.3 ± 1.4, respectively; p = 0.038) and lower mitral peak E velocities (40.1 ± 11.3 
vs 48.0 ± 7.3 cm/s; p = 0.024) than DM2 patients without coronary calcification. PFR nor-
malized to SV was independently associated with the presence of coronary artery calcifica-
tion (β = –1.5, p = 0.005).
CONCLUSION. DM2 decreases cardiovascular MRI–derived parameters of LV dia-
stolic function. Patients with DM2 and coronary atherosclerosis show a more impaired LV 
diastolic function than patients without coronary atherosclerosis.
Graça et al.
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associated with lower LV ejection fractions 
(LVEFs) and peak filling rates (PFRs), as 
assessed with cardiac MRI. The results of a 
study by Eleid et al. [14] pointed to differ-
ent conclusions. Their results in asymptom-
atic patients with a normal LVEF and nega-
tive findings on a cardiac stress test showed 
that CAC does not correlate with LV diastol-
ic function as defined by established Doppler 
echocardiographic criteria.
Although all of these studies included pa-
tients with DM2, none specifically studied 
this population. Accordingly, the purpose of 
this study was to compare cardiac MRI–de-
rived parameters of diastolic function be-
tween well-controlled uncomplicated DM2 
and normoglycemic control subjects and to 
evaluate whether these cardiac MRI–derived 
parameters of LV diastolic function are relat-
ed to coronary atherosclerosis.
Cardiac MRI was used to measure pa-
rameters of LV diastolic function, and the 
presence of coronary atherosclerosis was as-
sessed by means of CAC scoring.
We hypothesized that in asymptomatic 
diabetic patients diastolic function as mea-
sured by mitral flow velocities and PFR will 
be reduced with the presence of coronary 
atherosclerosis. We also hypothesized that 
asymptomatic diabetic patients will have re-




We prospectively enrolled 41 subjects (21 wom-
en and 20 men) with DM2 referred to the outpatient 
clinical Department of Diabetology of our institu-
tion and 21 age- and sex-matched normoglycemic 
control subjects (nine women and 12 men) recruit-
ed from the community.
Subjects were included if they met the fol-
lowing inclusion criteria: age between 45 and 75 
years, no symptoms or history of overt heart dis-
ease (cardiomyopathy, coronary artery disease, or 
valvular heart disease), no signs or symptoms of 
cerebrovascular disease, no abnormal findings on 
routine clinical and physical examinations, and 
normal ECG results.
Exclusion criteria were an LVEF of less than 55%, 
regional LV wall motion abnormalities, and valvu-
lar heart diseases assessed by cardiovascular MRI; 
severe renal failure; claustrophobia; cardiovascular 
MR images unsuitable for quantification; type 1 dia-
betes mellitus; severely uncontrolled diabetes melli-
tus (defined as glycated hemoglobin > 12%); and un-
controlled blood pressure at rest (defined as systolic 
blood pressure > 180 mm Hg or diastolic blood pres-
sure > 100 mm Hg). Subjects with contraindications 
to cardiovascular MRI were not enrolled.
The study was approved by our institutional 
ethics committee. Each subject gave written in-
formed consent.
Coronary Artery Calcium Score, Data 
Acquisition, and Analysis
CAC scoring was performed only in the DM2 
group. For this purpose, unenhanced low-dose 
ECG-gated scanning using a 64-MDCT scanner 
(LightSpeed VCT XT, GE Healthcare) was per-
formed with prospective triggering at 75% of the 
R-R interval. All examinations included the entire 
coronary tree and were performed with the patient 
breath-holding in inspiration. The scanning param-
eters were as follows: FOV, 25 cm; slice thickness, 
2.5 mm; gantry rotation time, 0.35 second; tube 
current, 100–400 mA; and tube voltage, 120 kV.
The CAC score was determined by an experi-
enced observer using dedicated software (Smart-
Score version 4.0, GE Healthcare). The total CAC 
score was calculated for each patient using the Ag-
atston method [15]. For the final analysis, patients 
were categorized in one of two groups: group 1, 
CAC score greater than 0; or group 2, CAC score 
equal to 0.
Cardiac MRI Protocol
Cardiac MRI was performed using a 3-T unit 
(Magnetom Trio, Siemens Healthcare). Cardiac 
cine images were acquired using steady-state free-
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normoglycemic man. Left 
ventricular (LV) filling 
volume versus time curve 
and its first derivative, 
peak filling rate (PFR) 
curve, are obtained after 
endocardial delineation 
of all LV short-axis slices 
across all temporal 
phases. PFR is steepest 
tangent (line) to first 
part of filling curve and 
represents most rapid 
ventricular filling. PFR 
value obtained was 394 
mL/s. 
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Fig. 2—45-year-old man 
with type 2 diabetes 
mellitus. Left ventricular 
filling volume versus time 
curve and peak filling 
rate (PRF) obtained (269 
mL/s) are shown. PFR is 
steepest tangent (line) to 
first part of filling curve 
































































AJR:202, June 2014 1209
MRI of LV Diastolic Function in DM2 Patients
precession sequences with retrospective ECG gat-
ing [16]. Participants were imaged in the supine 
position and performed a breath-hold at end ex-
piration for each image acquisition to eliminate 
respiratory motion artifacts. After scout images 
were obtained, cine imaging was performed in 
four-chamber, three-chamber, and two-chamber 
long- and short-axis views with the use of the fol-
lowing parameters: 8-mm-thick sections with a 
2-mm gap between sections; TR/TE, 59.04/1.45; 
number of segments, 18; flip angle, 50°; matrix, 
256 × 156; pixel size, 2.1 × 1.6 mm; acquired tem-
poral resolution, 25–40 ms; and number of recon-
structed cardiac phases, 25.
A breath-held retrospectively vector ECG-gat-
ed 2D flow-sensitive phase-contrast gradient-echo 
sequence was used for velocity-encoded MRI flow 
measurements perpendicular to the orifice of the 
mitral valve. Velocity-encoded MRI slices were 
positioned in early diastole at the tip of the mitral 
valve leaflets. Typical imaging parameters of ve-
locity-encoded MRI were as follows: slice thick-
ness, 6 mm; TR/TE, 35.6/2.33; number of seg-
ments, 3; acquired temporal resolution, 24–56 
ms; flip angle, 20°; 25 calculated phases; and pix-
el spacing, 4.5 × 3.1 mm. The encoding velocity 
was set to 130 cm/s [9].
MR Image Analysis
Quantitative image data analysis was per-
formed using dedicated software (Segment ver-
sion 1.9, Medviso) [17]. All functional evaluations 
were performed within 25 minutes per patient.
Tracing of Endocardial and Epicardial Contours
All measurements were undertaken semiauto-
matically. End-diastolic and end-systolic frames 
were identified according to the ventricular blood 
pool area. In all LV short-axis slices across all tem-
poral phases (200–250 images), endocardial and 
epicardial contours were semiautomatically drawn 
and were manually corrected (Fig. 1). This segmen-
tation took 3–5 minutes. At the base of the left ven-
tricle, the aortic outflow tract below the valve was in-
cluded in volume measurements. The free papillary 
muscles were included for LV mass assessment and 
were excluded for LV volume assessment. In the bas-
al region of the heart where the left atrium was seen, 
only the portion of the slice that could be identified 
as the left ventricle was included for measurement.
This analysis provided the time-varying course of 
the LV volume during the cardiac cycle. The PFR 
is the steepest tangent to the first part of the filling 
curve (Fig. 2). Segment software automatically de-
termines this parameter.
Analysis of the Transmitral Flow
In the flow-sensitive sequence, a round region 
of interest with a minimum size of 1 cm2 was 
placed at the center of the mitral valve orifice on a 
diastolic image and propagated to other phases to 
obtain the transmitral curve [9]. From the analysis 
of the transmitral flow curve, the following mea-
surements were performed: early phase of ventric-
ular filling (E) and atrial phase of ventricular fill-
ing (A) mean peak velocities (in centimeters per 
second) and peak E velocity–to–peak A velocity 
(E/A) ratio.
Statistical Analysis
All continuous variables were tested for normal 
distribution. All normally distributed data are ex-
pressed as means ± SDs. Categoric variables are 
expressed as counts and percentages. Between-
group differences of the average were compared 
using the unpaired Student t test for paramet-
ric data and the Mann-Whitney U test for non-
parametric data. Between-group differences in 
numbers and percentages were compared using 
the chi-square test (Fisher exact test).
The distribution of CAC scores was skewed; 
therefore, medians and ranges are reported.
Logarithmic transformation of CAC scores—
that is, log (total CAC score + 1)—was used for 
parametric evaluation.
The Pearson correlation test was used for sets 
of normal variables. Independent associations be-
tween coronary artery calcification and LV dia-
stolic values were studied using a linear regres-
sion with multivariable adjustments for potentially 
confounding factors (e.g., age, sex, history of hy-
pertension, body mass index [BMI], duration of 
diabetes, LVEF, and LV mass index).
All p values of < 0.05 were considered statisti-
cally significant. All computations were performed 
using software (SPSS, version 20.0, SPSS).
Results
Forty-one DM2 patients and 21 age- and 
sex-matched normoglycemic control sub-
jects were studied. Demographic, clinical, 
and imaging data of the patients and control 
subjects are presented in Table 1. The mean 
age was 57.2 ± 7.1 years (age range, 45–72 
years) and 32 (52%) patients were male.
As expected, patients with DM2 had high-
er BMI (p < 0.001) than control subjects. 
Our population of DM2 patients had a higher 
prevalence of systemic arterial hypertension 
(p = 0.001) compared with control subjects.
Left Ventricular Function
Patients with DM2 had normal conven-
tional parameters of systolic function includ-
TABLE 1: Characteristics of the Study Population
Characteristics DM2 Group (n = 41) Control Subjects (n = 21) p
Age (y), mean ± SD 58.2 ± 7.2 54.9 ± 6.5 0.078
Sex, no. (%) of subjects 0.533
Male 20 (49) 12 (57)
Female 21 (51) 9 (43)
BSA (m2), mean ± SD 1.85 ± 0.21 1.80 ± 0.16 0.359
BMI (kg/m2), mean ± SD 29.3 ± 4.6 25.0 ± 1.7 < 0.001
Diabetes duration (y), mean ± SD 13.3 ± 8.9 —
Hypertensiona, no. (%) of subjects 30 (73) 6 (29) 0.001
LV EDV (mL), mean ± SD 96.3 ± 20.8 118.7 ± 25.1 0.001
LV EDV/BSA (mL/m2), mean ± SD 52.2 ± 10.9 65.6 ± 11.4 < 0.001
LV SV (mL), mean ± SD 63.7 ± 14.5 79.9 ± 14.4 < 0.001
LVEF (%), mean ± SD 66.7 ± 8.0 67.9 ± 5.3 0.485
LV mass/BSA (g/m2), mean ± SD 68.2 ± 13.6 65.6 ± 10.0 0.474
LV PFR (mL/s), mean ± SD 293.2 ± 51.7 375.7 ± 102.8 < 0.001
LV PFR/EDV (mL/s), mean ± SD 3.1 ± 0.7 3.2 ± 0.8 0.616
LV PFR/SV (mL/s), mean ± SD 4.7 ± 1.1 4.7 ± 1.0 0.979
Mitral peak E velocity (cm/s), mean ± SD 42.8 ± 10.7 48.8 ± 10.4 0.040
Mitral peak A velocity (cm/s), mean ± SD 49.8 ± 11.2 45.0 ± 8.6 0.069
Mitral E/A ratio, mean ± SD 0.88 ± 0.3 1.1 ± 0.3 0.002
Note—Dash (—) indicates not applicable. DM2 = type 2 diabetes mellitus, BSA = body surface area, BMI = 
body mass index, LV = left ventricular, EDV = end-diastolic volume, SV = stroke volume, LVEF = left ventricular 
ejection fraction, PFR = peak filling rate, E/A ratio = peak E velocity–to–peak A velocity ratio.
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ing LVEF and a normal LV mass index com-
pared with control subjects.
The absolute values of PFR were signifi-
cantly higher in the control subjects (Fig. 1) 
than in the DM2 patients (Fig. 2) (p < 0.001).
The values of PFR indexed to end-diastol-
ic volume (EDV) and stroke volume (SV) in 
DM2 patients and control subjects were sim-
ilar (p = 0.616, p = 0.979, respectively).
An analysis of the transmitral parameters 
showed lower mitral peak E velocities (p = 
0.040) and lower E/A ratios (p = 0.002) in 
DM2 patients compared with control sub-
jects. Mitral peak A velocities were higher 
in the DM2 group, although not significantly 
so (p = 0.069).
To further address the relationship be-
tween hypertension and diastolic dysfunc-
tion in the patient population, we performed 
a subgroup analysis of the parameters of dia-
stolic dysfunction in the DM2 group accord-
ing to the presence or absence of hyperten-
sion. The results obtained are presented in 
Table 2.
In this subgroup comparison, all param-
eters of LV diastolic function were similar in 
both groups.
Coronary Atherosclerosis
In the DM2 group, the average CAC score 
was 344 ± 754 (SD) (range, 0–4697). CAC 
was absent in 14 (34%) DM2 patients and 
was less than 10 in 18 (44%) DM2 patients. 
Nine of 42 (21%) DM2 patients had CAC 
scores greater than 10.
Parameters of Diastolic Function and 
Calcium Score
Table 3 shows baseline and LV systolic 
and diastolic parameters of DM2 patients ac-
cording to the presence or absence of coro-
nary artery calcification.
DM2 patients with coronary calcification 
were older (p = 0.018) and had longer dura-
tion of diabetes mellitus, although not signif-
icantly so (p = 0.060). Comparing DM2 pa-
tients according to the presence or absence 
of coronary calcification, we found no dif-
ferences in terms of sex, body surface area 
(BSA), BMI, or the presence of hyperten-
sion. The analysis of LV systolic function 
and LV mass also showed no statistically 
significant difference between DM2 patients 
with coronary calcification and those with-
out coronary calcification.
Regarding the parameters of diastolic 
function, DM2 patients with coronary cal-
cification showed lower PFR/SV (Fig. 3) 
(p = 0.038) and lower mitral peak E veloci-
Time (ms)


























PFR = 357 mL/s
PFR/SV = 3.72 mL/s
A
Fig. 3—67-year-old man with type 2 diabetes mellitus and coronary artery calcification. 
A, Left ventricular filling volume versus time curve and peak filling rate (PFR) obtained (357 mL/s). PFR is steepest tangent (line) to first part of filling curve and represents 
most rapid ventricular filling. PFR indexed to stroke volume (PFR/SV) was 3.72 mL/s.
B, CT image used for coronary artery calcium scoring shows coronary artery calcifications (arrow). Agatston calcium score calculated by CT was 410.
B
TABLE 2: Left Ventricular (LV) Diastolic Function Parameters in the Type 
2 Diabetes Mellitus (DM2) Group According to the Presence or 
Absence of Systemic Arterial Hypertension
Parameters
Group With DM2 Only 
(n = 11), Mean ± SD
Group With DM2 and Systemic 
Arterial Hypertension (n = 30), 
Mean ± SD p
LV PFR (mL/s) 293.0 ± 52.6 292.1 ± 52.7 0.964
LV PFR/EDV (mL/s) 3.0 ± 0.8 3.2 ± 0.7 0.356
LV PFR/SV (mL/s) 4.5 ± 1.1 4.8 ± 1.2 0.454
Mitral peak E velocity (cm/s) 43.0 ± 9.4 42.8 ± 11.4 0.948
Mitral peak A velocity (cm/s) 50.4 ± 6.5 49.5 ± 12.6 0.774
Mitral E/A ratio 0.85 ± 0.19 0.89 ± 0.27 0.610
Note—PFR = peak filling rate, EDV = end-diastolic volume, SV = stroke volume, E/A ratio = peak E velocity–to–
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ties (p = 0.024) compared with DM2 patients 
without coronary calcification (Fig. 4).
Univariable and Multivariable Analyses
In the DM2 group, an increasing CAC 
score was negatively correlated with PFR/SV 
(r = –0.68, p < 0.001) (Fig. 5).
By multivariable analysis, PFR/SV was 
independently associated with the presence 
of coronary calcification (β = –1.5, p = 0.005) 
after adjustment for age, sex, BMI, presence 
of hypertension, diabetes duration, LVEF, 
and LV mass index.
Discussion
In this study, CAC score and parameters of 
diastolic function in patients with DM2 were 
investigated. There were two major observa-
tions. First, differences in diastolic function 
were observed between DM2 patients and 
control subjects—in particular, in LV PFR 
values, mitral peak E velocities, and E/A ra-
tios. Second, the parameters of diastolic func-
tion were different between DM2 patients 
with coronary calcification and those with-
out coronary calcification—in particular, LV 
PFR/SV values and mitral peak E velocities.
Differences in Left Ventricular Diastolic Measures
LV filling profiles have been used to as-
sess diastolic function by other imaging in-
vestigations, such as radionuclide cineangi-
TABLE 3:  Characteristics of Patients With Type 2 Diabetes Mellitus According 
to the Presence or Absence of Coronary Artery Calcification
Characteristics
Calcium Score > 0 
(n = 27)
Calcium Score = 0 
(n = 14) p
Age (y), mean ± SD 60.2 ± 6.7 54.6 ± 6.8 0.018
Sex, no. (%) of patients 0.228
Male 15 (56) 5 (36)
Female 12 (44) 9 (64)
BSA (m2), mean ± SD 1.86 ± 0.17 1.84 ± 0.27 0.763
BMI (kg/m2), mean ± SD 29.1 ± 4.5 30.0 ± 4.6 0.550
Diabetes duration (y), mean ± SD 14.9 ± 9.0 9.4 ± 8.4 0.060
Hypertensiona, no. (%) of patients 19 (70) 11 (79) 0.574
LV EDV (mL), mean ± SD 97.5 ± 22.7 93.9 ± 17.1 0.567
LV EDV/BSA (mL/m2), mean ± SD 52.4 ± 10.8 51.8 ± 11.4 0.863
LV SV (mL), mean ± SD 65.9 ± 15.6 59.4 ± 11.5 0.139
LVEF (%), mean ± SD 68.3 ± 8.9 63.7 ± 6.6 0.065
LV mass/BSA (g/m2), mean ± SD 70.9 ± 14.3 63.1 ± 10.6 0.055
LV PFR (mL/s), mean ± SD 286.6 ± 54.2 306.4 ± 45.3 0.220
LV PFR/EDV (mL/s), mean ± SD 3.0 ± 0.7 3.4 ± 0.8 0.142
LV PFR/SV (mL/s), mean ± SD 4.4 ± 1.0 5.3 ± 1.4 0.038
Mitral peak E velocity (cm/s), mean ± SD 40.1 ± 11.3 48.0 ± 7.3 0.024
Mitral peak A velocity (cm/s), mean ± SD 49.8 ± 13.2 49.8 ± 6.2 0.997
Mitral E/A ratio, mean ± SD 0.83 ± 0.3 0.96 ± 0.2 0.086
Note—BSA = body surface area, BMI = body mass index, LV = left ventricular, EDV = end-diastolic volume, SV = 
stroke volume, LVEF = left ventricular ejection fraction, PFR = peak filling rate, E/A ratio = peak E velocity–to–
peak A velocity ratio.
aBlood pressure > 140/90 mm Hg or treatment with antihypertensive medication.
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PFR = 347 mL/s
PFR/SV = 5.18 mL/s
A
Fig. 4—55-year-old woman with type 2 diabetes mellitus and no coronary artery calcification. 
A, Left ventricular filling volume versus time curve and peak filling rate (PFR) obtained (347 mL/s). PFR is steepest tangent (line) to first part of filling curve and represents 
most rapid ventricular filling. PFR indexed to stroke volume (PFR/SV) was 5.18 mL/s. 
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ography and SPECT. Similar applications 
for cardiac MRI have been impractical be-
cause manual planimetry of all LV images 
across all temporal phases would typically 
require tracing of more than 200 images per 
patient. With improvements in postprocess-
ing tools, it is now possible to semiautomati-
cally segment all phases and quickly provide 
the time-varying course of the LV volume 
during the cardiac cycle. The ventricular re-
laxation abnormalities can be diagnosed by 
a low PFR. This evaluation is based on con-
ventional short-axis sequences without the 
necessity to perform a dedicated acquisition. 
The use of PFR values indexed to EDV and 
SV minimizes the dependency of PFR on 
EDV and heart rate. We found that the LV 
PFR can be easily obtained as an addition to 
the assessment of LV systolic function with 
semiautomatic contour detection and it may 
become a valuable asset in the evaluation of 
LV diastolic function.
In this study, parameters of LV diastol-
ic function were impaired in DM2 patients 
compared with normoglycemic control sub-
jects. The mitral peak E velocity, E/A ratio, 
and LV PFR were lower in DM2 patients, in-
dicating impaired myocardial relaxation and 
increased myocardial stiffness, which are 
the hallmarks of diastolic dysfunction [18]. 
DM2-related changes in LV diastolic prop-
erties are well recognized with a decrease in 
early diastolic filling, directly influenced by 
abnormal LV relaxation, mainly due to a de-
rangement in energy supply and an increased 
passive stiffness due to remodeling [19].
We acknowledge that coexisting arterial 
hypertension augments the impairment of 
LV diastolic function in diabetic patients and 
may partially explain the changes reported.
Interestingly, Di Bonito et al. [20] observed 
diastolic dysfunction in 16 normotensive pa-
tients with DM2 without microvascular com-
plications and a short disease duration (< 1 
year). Likewise, previous studies have shown 
that more than 40–75% of normotensive di-
abetic patients under excellent glycemic con-
trol had diastolic dysfunction [1, 2, 21]. In our 
study, the parameters of diastolic function 
were not different in the patients with DM2 
and hypertension compared with the DM2 pa-
tients without hypertension.
Diastolic Function and Coronary 
Atherosclerosis
Our study of DM2 patients shows an asso-
ciation between diastolic function assessed 
by cardiac MRI and coronary artery calcifi-
cation assessed by CT.
In our cohort of DM2 patients, lower 
PFR/SV and lower mitral peak E values were 
significantly associated with coronary calci-
fication. Furthermore, the presence of coro-
nary calcification was independently associ-
ated with PFR/SV, increasing the strength of 
this association. Our results are consistent 
with the findings of other studies. Colletti et 
al. [13] studied 386 subjects, including 39 pa-
tients with diabetes mellitus, and also found 
a relation of a CAC score of greater than 100 
with decreased MRI–derived parameters of 
LV diastolic filling. Scholte et al. [22] report-
ed similar conclusions using echocardiog-
raphy-derived indexes of diastolic function 
(transmitral and pulmonary vein flow re-
cording) and systolic function (global longi-
tudinal strain). Their results point to an as-
sociation of coronary atherosclerosis with 
subclinical LV dysfunction evaluated in 
DM2 patients [22].
Mechanisms underlying the relationship of 
subclinical atherosclerosis and diastolic func-
tion are probably related to vascular function.
Poulsen et al. [23] suggested that abnor-
mal LV filling in DM2 patients is closely 
associated with abnormal myocardial per-
fusion on myocardial perfusion scintigra-
phy. Macrovascular coronary artery disease 
could also contribute to this subclinical myo-
cardial damage [22]. In coronary macrovas-
culature, formation of atheroma may lead to 
luminal obliteration, recurrent thrombosis, 
distal embolization, and clinically silent mi-
croinfarctions [11].
The findings of this study contribute to 
the available knowledge, favoring the hy-
pothesis that there is a link between sub-
clinical LV diastolic dysfunction and as-
ymptomatic atherosclerosis.
In our study, the DM2 patients with coro-
nary artery calcification had greater LV mass 
than the DM2 patients without coronary cal-
cification, but the difference did not quite 
achieve acceptable levels of statistical sig-
nificance (p = 0.055). LV mass represents 
an endpoint of cumulative LV insult, and al-
though not a diagnostic criteria for LV diastol-
ic dysfunction, increased LV mass is associ-
ated with diastolic dysfunction ranging from 
abnormal relaxation to coexistent restrictive 
physiology due to increased myocardial stiff-
ness [24]. Systemic arterial hypertension and 
diabetes mellitus are known causes of LV hy-
pertrophy. Notwithstanding the high preva-
lence of arterial hypertension in our popu-
lation, none of our subjects had an LV mass 
above the normal range (LV mass indexed to 
BSA > 86 g/m2
 for men and > 72 g/m2 for 
women) [25, 26].
The originality of our study is the use of 
cardiac MRI–derived parameters of diastol-
ic function and the relatively high number of 
DM2 patients with a low CAC score. We had 
a relatively large percentage of DM2 patients 
PFR/SV (mL/s)























Fig. 5—Scatterplot and linear fit of relationship of peak filling rate (PFR) indexed to stroke volume (PFR/SV) 
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with a CAC score equal to zero, something 
that we were not expecting in a population 
of DM2 patients between the ages of 45 and 
72 years.
A basic limitation of this study must be 
acknowledged. This study was a cross-sec-
tional study with a relatively small number 
of subjects; therefore, studies using larger 
patient cohorts are needed to clarify the as-
sociation between LV diastolic function and 
coronary atherosclerosis.
Our findings are limited by an inability to 
eliminate causal relationships with important 
clinical factors, such as medications used, se-
rum concentrations of glucose and glycosylat-
ed hemoglobin (HbA1c), dyslipidemia, retinop-
athy, microalbuminuria, and smoking status. 
Also, the high prevalence of hypertension in 
our population makes it difficult to interpret the 
findings and clarify the responsibility of diabe-
tes in the results obtained.
The possibility of influence of myocardial 
ischemia on LV diastolic function cannot be 
completely excluded. The evaluation of cor-
onary stenosis and plaque characterization 
were not performed in our study because CT 
angiography is not recommended in asymp-
tomatic DM2 patients. Because myocardial 
perfusion, endothelial function, coronary flow 
reserve, and arterial stiffness were not evalu-
ated in the current study, a more comprehen-
sive understanding of the pathophysiologic 
process should be the focus of future research.
We consider the analysis of cine and trans-
mitral flow images to be sufficient to exclude 
left-sided valvular disease as a potential pit-
fall of abnormal transmitral flow. Regarding 
the exclusion of infiltrative myocardial dis-
ease, we neither studied myocardial delayed 
enhancement nor performed endomyocardi-
al biopsy. Nevertheless, none of our subjects 
had increased LV myocardial end-diastolic 
thickness, pericardial thickening, pericardial 
effusion, or pleural effusion.
Recent findings [27] have shown an im-
provement in transmitral flow assessment by 
applying 3D three-directional velocity-en-
coding instead of the conventional approach 
of 2D one-directional through-plane veloc-
ity-encoded MRI with a fixed acquisition 
plane used in our study.
Normalizing early mitral velocity (E) for 
the influence of myocardial relaxation by 
combining E with early diastolic mitral sep-
tal tissue velocity (Ea) may be performed by 
MR tissue phase-contrast imaging, and this 
is an important parameter of diastolic func-
tion that has been established [28]. On the 
other hand, there are still conflicting data re-
garding the relation of E/Ea ratio and LV fill-
ing pressure [29, 30].
The evaluation of coronary stenosis and 
characterization of plaque were not per-
formed in our study because CT angiogra-
phy is not recommended in asymptomatic 
DM2 patients.
This study highlights certain key points for 
the routine use of cardiac MRI to study diastol-
ic function in diabetic patients and the relation 
of diastolic function with coronary atheroscle-
rosis. First, cardiac MRI shows a decrease in 
diastolic function in DM2 and may allow the 
diagnosis of subclinical diastolic dysfunction 
in this high-risk population. Second, diastolic 
dysfunction is possibly related to the presence 
of coronary atherosclerosis.
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